RAD media and Publications, page-37

Whilst it's good to see the coverage, the quality and value of these "analysts" reports ????
At look at the various Analysts reports on all the Hopper stable of companies all give a circa 75c target
Maybe the AI algo sees "Hopper" and just assigns the given number.

A view of CHM preso yesterday from the 11:30 to 14:30 mark highlights the lack of innovation in treatment options for Glioblastoma (GBM), emphasising the opportunity that RADs recent isotope deal and development of RAD 602 means for patient outcomes.

RAD has all the elements to be something very special